loadpatents
Patent applications and USPTO patent grants for Monneaux; Fanny Sylvie-Michele.The latest application filed is for "phosphorylated derivatives of a u1-70k peptide and their use in the treatment of autoimmune pathologies".
Patent | Date |
---|---|
Phosphorylated Derivatives Of A U1-70k Peptide And Their Use In The Treatment Of Autoimmune Pathologies App 20140004136 - Muller; Sylviane ;   et al. | 2014-01-02 |
Phosphorylated derivatives of a U1-70K peptide and their use in the treatment of autoimmune pathologies Grant 8,475,800 - Muller , et al. July 2, 2 | 2013-07-02 |
Use Of Peptides Comprising Post-translational Modifications In The Treatment Of Autoimmune Pathologies App 20120149652 - MULLER; Sylviane ;   et al. | 2012-06-14 |
Use of adenine-derived compounds for the treatment of lupus Grant 8,058,281 - Lugnier , et al. November 15, 2 | 2011-11-15 |
Phosphorylated derivatives of a U1-70K peptide and their use in the treatment of autoimmune pathologies Grant 7,872,098 - Muller , et al. January 18, 2 | 2011-01-18 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.